Dr. Michael S. Frontiera, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 180
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
WI license 27625-020
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 180
- Services billed
- 16,333
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, dexamethasone sodium phosphate, 1 mg | 1,064 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 449 | 209 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 311 | 108 |
| Insertion of needle into vein for collection of blood sample | 256 | 121 |
| Blood test, comprehensive group of blood chemicals | 196 | 53 |
| Injection of additional new drug or substance into vein | 188 | 24 |
| Administration of chemotherapy into vein, 1 hour or less | 167 | 42 |
| Established patient office or other outpatient visit, 20-29 minutes | 109 | 74 |
| Injection, zoledronic acid, 1 mg | 91 | 16 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 55 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Madison, WI | 444 |
| Tamoxifen Citrate Other prescribers in Madison, WI | 35 |
| Alendronate Sodium Other prescribers in Madison, WI | 30 |
| Exemestane | 24 |
| Xtandi (enzalutamide) | 22 |
| Imbruvica (ibrutinib) | 21 |
| Lynparza (olaparib) | 18 |
| Letrozole Other prescribers in Madison, WI | 15 |
| Brukinsa (zanubrutinib) | 13 |
| Ibrance (palbociclib) | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $1,665 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $1,665 |
|---|
| Consulting Fee | $1,665 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Jan 11, 2025 | Consulting Fee | $1,665 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.